Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Aug 16, 2023 12:56pm
219 Views
Post# 35591234

We have FDA approval on the New Drug Application!!!

We have FDA approval on the New Drug Application!!!I hope everyone realizes this and it is up to Medipharm Labs and their global pharmaceutical partner to release that news.   

Mr. Pidduck, the CEO of Medipharm Labs stated something very important but I don't think a lot of people were really listening and paying attention to his words.   

He stated very, very, clearly:  we are waiting on the new drug monograph

That simply means, the FDA has approved the N.D.A. and that puts Mr. Pidduck and Medipharm Labs now in a waiting mode for the FDA to simply process and issue it through their system.

Athea and I, especially Athea, were waiting patiently for someone else to realize that.   You don't WAIT for a new drug monograph if the drug did not get approved by the FDA.  

So hold on boys and girls!!!
<< Previous
Bullboard Posts
Next >>